Anticancer Mechanism of Melia azedarach, Doxorubicin and Cyclosphamide Combination against Breast Cancer in Mice
Background: Previous studies show that Mindi (Melia azedarach) has a potent cytotoxicity effect on MCF-7 via induction of apoptosis and cell cycle arrest. However its mechanism has not been established. This study was performed to determine the anti-cancer activity of Melia azedarach, doxorubicin, and cyclosphamide combination and to elucidate the underlying mechanism of this activity in mice.
Study design and methods: This was an experimental study with a posttest control group design. Twenty four C3H mice inoculated with adenocarsinoma mammary were divided into four groups receiving one of the following treatment: Aquadest,combination of doxorubicin and cyclosphamide (dox-cyc); Melia azedarach, doxorubicin, cyclosphamide (MA-dox-cyc) combination; Melia azedarach alone (MA) respectively. BAX expression was determined by Immunohistochemistry.
Results and conclusion: A significant decrease in tumor volume was found in combination group. This decrease might have been due to the significant increase is in BAX expression and decrease in AgNOR expression compared with that of control (p <0.05). In conclusion, the combination of Melia azedarach, doxorubicin, cyclosphamide can decrease volume of adenocarsinoma mammary tumors in C3H mice via BAX expression increasing and decreasing AgNOR expression.
Bangladesh Journal of Medical Science Vol.16(3) 2017 p.428-432
Copyright (c) 2017 Titik Sumarawati, - Israhnanto, Dina Fatmawati
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish in the Bangladesh Journal of Medical Science agree to the following terms that:
- Authors retain copyright and grant Bangladesh Journal of Medical Science the right of first publication of the work.
Articles in Bangladesh Journal of Medical Science are licensed under a Creative Commons Attribution 4.0 International License CC BY-4.0.This license permits use, distribution and reproduction in any medium, provided the original work is properly cited.
- Authors are able to enter into separate, additional contractual arrangements for the distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted to post their work online (e.g., in institutional repositories or on their website) as it can lead to productive exchanges, as well as greater citation of published work.